Aditxt is trading 10% down now at $0.00 amid ongoing volatility following its recently announced third reverse stock split in seven months.

  • The sharp decline follows heavy selling pressure as traders react to the company's third split within a seven-month period.
  • Broader risk-off sentiment across the small-cap biotech sector is contributing to the downward momentum.
  • No new company-specific news or earnings reports have been released this morning to account for the move.